IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 282 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
Tatsuaki Takeda,Hiromasa Yamamoto,Hirotaka Kanzaki,Ken Suzawa,Takahiro Yoshioka,Shuta Tomida,Xiaojiang Cui,Ramachandran Murali,Kei Namba,Hiroki Sato,Hidejiro Torigoe,Mototsugu Watanabe,Kazuhiko Shien,Junichi Soh,Hiroaki Asano,Kazunori Tsukuda,Yoshihisa Kitamura,Shinichiro Miyoshi,Toshiaki Sendo,Shinichi Toyooka,Ming Tan
PLOS ONE.2017;12(2)e0171356
[DOI]
2Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
Anusha Sebastian,Vijay Pandey,Chakrabhavi Dhananjaya Mohan,Yi Ting Chia,Shobith Rangappa,Jessin Mathai,C. P. Baburajeev,Shardul Paricharak,Lewis H. Mervin,Krishna C. Bulusu,Julian E. Fuchs,Andreas Bender,Shuhei Yamada,Shuhei Basappa,Peter E. Lobie,Kanchugarakoppal S. Rangappa
ACS Omega.2016;1(6)1412
[DOI]
3Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
Salman M. Hyder,Benford Mafuvadze,Cynthia Besch-Williford
ACS Omega.2013;1(6)123
[DOI]
4A Brief Literature and Review of Patents on Thiazole Related Derivatives
Diksha Sharma,Kushal K. Bansal,Archana Sharma,Meenakshi Pathak,Prabodh C. Sharma
Current Bioactive Compounds.2019;15(3)304
[DOI]
5Immunotherapy for Breast Cancer Treatment
Miganoosh Simonian,Mozhan Haji Ghaffari,Babak Negahdari
Iranian Biomedical Journal.2021;25(3)140
[DOI]
6Immunotherapy for Breast Cancer Treatment
Ruchika Kaul-Ghanekar,Snehal Suryavanshi,Prerna Raina
Iranian Biomedical Journal.2015;25(3)61
[DOI]
7Transforming growth factor-ß, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer
ABEER BAHHNASSY,MARWA MOHANAD,SABRY SHAARAWY,MANAL F. ISMAIL,AHMED EL-BASTAWISY,ABEER M. ASHMAWY,ABDEL-RAHMAN ZEKRI
Molecular Medicine Reports.2015;12(1)851
[DOI]
8Thiazole-containing compounds as therapeutic targets for cancer therapy
Prabodh Chander Sharma,Kushal Kumar Bansal,Archana Sharma,Diksha Sharma,Aakash Deep
European Journal of Medicinal Chemistry.2020;188(1)112016
[DOI]
9Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer
Quanxia Lv,Ziyuan Meng,Yuanyuan Yu,Feng Jiang,Daogang Guan,Chao Liang,Junwei Zhou,Aiping Lu,Ge Zhang
International Journal of Molecular Sciences.2016;17(12)2095
[DOI]
10Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt
Abeer Bahnassy,Marwa Mohanad,Manal F. Ismail,Sabry Shaarawy,Ahmed El-Bastawisy,Abdel-Rahman N. Zekri
Experimental and Molecular Pathology.2015;99(2)303
[DOI]
11Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt
Adnan Aydiner
Experimental and Molecular Pathology.2016;99(2)535
[DOI]
12Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions
Youbang Xie,Yali Qi,Yanmiao Zhang,Jiayi Chen,Tianyi Wu,Yuhai Gu
Oncology Letters.2017;13(5)2909
[DOI]
13Targeted therapies in breast cancer: New challenges to fight against resistance
Viviana Masoud,Gilles Pagès
World Journal of Clinical Oncology.2017;8(2)120
[DOI]
14Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell
Jhi Biau Foo,May Lee Low,Ji Hui Lim,Yan Zhi Lor,Rusyidah Zainol Abidin,Vilasini Eh Dam,Napsiah Abdul Rahman,Chaw Yee Beh,Lee Chin Chan,Chee Wun How,Yin Sim Tor,Latifah Saiful Yazan
BioMetals.2018;31(4)505
[DOI]
15Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression
LIN WANG,GUIYING WANG,DANDAN YANG,XUDONG GUO,YANXIN XU,BO FENG,JIUHONG KANG
Molecular Medicine Reports.2013;8(4)1279
[DOI]
16Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer
Eden R. Padayachee,Fleury Augustin Nsole Biteghe,Zaria Malindi,Dirk Bauerschlag,Stefan Barth
Transfusion Medicine and Hemotherapy.2017;44(5)303
[DOI]
17microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R
KANG HAN,TINGBAO ZHAO,XIANG CHEN,NA BIAN,TONGTAO YANG,QIONG MA,CHENGKUI CAI,QINGYU FAN,YONG ZHOU,BAOAN MA
International Journal of Oncology.2014;45(4)1437
[DOI]
18Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update
Carmen Chan,Bernard Law,Winnie So,Ka Chow,Mary Waye
International Journal of Molecular Sciences.2017;18(11)2423
[DOI]
19Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells
Vaiyapuri Subbarayan Periasamy,Jegan Athinarayanan,Ali A. Alshatwi
Ultrasonics Sonochemistry.2016;31(11)449
[DOI]
20Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion
Ji-Yeon Lee,Jie Min Kim,Da Som Jeong,Myoung Hee Kim
Biochemical and Biophysical Research Communications.2018;503(4)2924
[DOI]
21Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: Invasion, angiogenesis, metastasis and therapy
A.A. Santos,A.J.F. Matos
The Veterinary Journal.2015;205(2)144
[DOI]
22Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
Natalie J. Serkova,S. Gail Eckhardt
Frontiers in Oncology.2016;6(2)144
[DOI]
23The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer
Anna Mandel,Per Larsson,Martuza Sarwar,Julius Semenas,Azharuddin Sajid Syed Khaja,Jenny L. Persson
Molecular Medicine.2018;24(1)144
[DOI]
24Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin ß1
Yinying Dong,Xiaoying Xie,Zhiming Wang,Chao Hu,Qiongdan Zheng,Yaohui Wang,Rongxin Chen,Tongchun Xue,Jie Chen,Dongmei Gao,Weizhong Wu,Zhenggang Ren,Jiefeng Cui
Biochemical and Biophysical Research Communications.2014;444(3)427
[DOI]
25Inhibitor Response to HER2 G776YVMAIn-frame Insertion in HER2-positive Breast Cancer
Ya-Bing Zheng,Yang Yu,Bo Chen,Jin-Lin Hu,Tian Jing,Xi-Ping Zhang
Cancer Investigation.2016;34(3)123
[DOI]
26Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes
Osama A. Arshad,Priyadharshini S. Venkatasubramani,Aniruddha Datta,Jijayanagaram Venkatraj
IEEE Journal of Biomedical and Health Informatics.2016;20(1)399
[DOI]
27Lapatinib nano-delivery systems: a promising future for breast cancer treatment
Gunjan Vasant Bonde,Sarita Kumari Yadav,Sheetal Chauhan,Pooja Mittal,Gufran Ajmal,Sathish Thokala,Brahmeshwar Mishra
Expert Opinion on Drug Delivery.2018;15(5)495
[DOI]
28Retrospective review of genomic testing in breast cancer: Does it improve outcome?
Grady M. Gastelum,Cyrus Iqbal,Susan G. Hilsenbeck,Mothaffar F. Rimawi,Polly Niravath
Breast Cancer Research and Treatment.2017;163(1)191
[DOI]
29Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo
Wei Fan,Xiang Wang,Baoyue Ding,Haimin Cai,Xudong Wang,Yueqi Fan,Yong Li,Shenghui Liu,Suifeng Nie,Qiping Lu
Journal of Drug Targeting.2016;24(4)359
[DOI]
30The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy
A.A. Clancy,J.N. Spaans,J.I. Weberpals
Annals of Oncology.2016;27(9)1696
[DOI]
31Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy
Rohan Arora,Venkat Krishnan
Frontiers in Oncology.2017;7(9)1696
[DOI]
32‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
Mei S Ong,Wanpei Cai,Yi Yuan,Hin C Leong,Tuan Z Tan,Asad Mohammad,Ming L You,Frank Arfuso,Boon C Goh,Sudha Warrier,Gautam Sethi,Nicholas S Tolwinski,Peter E Lobie,Celestial T Yap,Shing C Hooi,Ruby Y Huang,Alan P Kumar
British Journal of Pharmacology.2017;174(24)4684
[DOI]
33Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies
Satish Kumar Vemuri,Rajkiran Reddy Banala,Sudip Mukherjee,Purushotham Uppula,Subbaiah GPV,Gurava Reddy A.V.,Malarvilli T.
Materials Science and Engineering: C.2019;99(24)417
[DOI]
34Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches
Sivakumar P. Malliappan,Palanivel Kandasamy,Siva Chidambaram,Devanand Venkatasubbu,Sathish K. Perumal,Abimanyu Sugumaran
Anti-Cancer Agents in Medicinal Chemistry.2020;20(11)1300
[DOI]
35Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting
Anna G. Sorace,Sara Harvey,Anum Syed,Thomas E. Yankeelov
Seminars in Oncology Nursing.2017;33(4)425
[DOI]
36IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors
Holly A. Porter,Anthony Perry,Chris Kingsley,Nhan L. Tran,Achsah D. Keegan
Cancer Letters.2013;338(2)239
[DOI]
37An update on the management of breast cancer in Africa
V. Vanderpuye,S. Grover,N. Hammad,N. PoojaPrabhakar,H. Simonds,F. Olopade,D. C. Stefan
Infectious Agents and Cancer.2017;12(1)239
[DOI]
38Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China
Jun Qiu,Rong Yang,Yanhua Rao,Yukai Du,Fatch W. Kalembo,Kamyar Afarinkia
PLoS ONE.2012;7(5)e36497
[DOI]
39Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer
David Riseberg
Clinical Medicine Insights: Oncology.2015;9(5)CMO.S26067
[DOI]
40Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer
Adnan Aydiner
Clinical Medicine Insights: Oncology.2019;9(5)463
[DOI]
41Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach
Balak Das Kurmi,Rishi Paliwal,Shivani Rai Paliwal
International Journal of Biological Macromolecules.2020;164(5)2881
[DOI]
42Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients
Monika Pizon,Dorothea Sonja Zimon,Ulrich Pachmann,Katharina Pachmann,Mohammad O. Hoque
PLoS ONE.2013;8(2)e56836
[DOI]
43Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
F-L Zhao,G-D Hu,X-F Wang,X-H Zhang,Y-K Zhang,Z-S Yu
Journal of International Medical Research.2012;40(3)859
[DOI]
44Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control study
Jalila Rahoui,Abdelilah Laraqui,Yassir Sbitti,Nadia Touil,Azeddine Ibrahimi,Brahim Ghrab,Abderrahman Al Bouzidi,Driss Moussaoui Rahali,Mohamed Dehayni,Mohamed Ichou,Fatima Zaoui,Saad Mrani
Medical Oncology.2014;31(9)859
[DOI]
45Experimental Models as Refined Translational Tools for Breast Cancer Research
Eduardo Costa,Tânia Ferreira-Gonçalves,Gonçalo Chasqueira,António S. Cabrita,Isabel V. Figueiredo,Catarina Pinto Reis
Scientia Pharmaceutica.2020;88(3)32
[DOI]
46Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
Qiang Yu,Yinmou Li,Shijun Peng,Jing Li,Xianxiong Qin
Open Medicine.2021;16(1)512
[DOI]
47Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations
Friedemann Schad,Jan Axtner,Matthias Kröz,Harald Matthes,Megan L. Steele
Integrative Cancer Therapies.2018;17(1)41
[DOI]
48Role of miRNAs in regulating responses to radiotherapy in human breast cancer
Zhi Xiong Chong,Swee Keong Yeap,Wan Yong Ho
International Journal of Radiation Biology.2021;97(3)289
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow